Entrada Therapeutics, Inc 10-K for FY2023
Entrada Therapeutics, Inc. (TRDA)
10-K
2024-03-13
For: 2023-12-31
View Original
Added on
April 10, 2026
About this 10-K
Entrada Therapeutics, Inc filed this 10-K on March 13, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $129.01M
- Net loss
- $6.69M
- compared with a net loss of $94.62M a year earlier
- Diluted EPS
- -$0.20
- compared with -$3.02 a year earlier